Wei Zhou

Publication Details

  • Endovascular repair of thoracic aortic disease: Overview of current devices and clinical results VASCULAR Lin, P. H., El Sayed, H. F., Kougias, P., Zhou, W., LeMaire, S. A., Coselli, J. S. 2007; 15 (4): 179-190

    Abstract:

    Endovascular repair of thoracic aortic aneurysm has become an important treatment modality in patients who are at increased risk for open surgical repair. Since the US Food and Drug Administration (FDA) approved the clinical application of this technology in the thoracic aorta in 2005, there has been a rapid growth in this treatment modality as numerous endovascular devices have been introduced in the application of thoracic aortic pathology. Although thoracic aortic aneurysm is the only FDA-approved treatment indication for endovascular repair, this technology may lead to a broader clinical applicability in other thoracic pathologies. This article reviews the current endovascular devices designed for the treatment of thoracic aortic pathology. These devices are described, and the current clinical results are discussed.

    View details for DOI 10.2310/6670.2007.00041

    View details for Web of Science ID 000249669000001

    View details for PubMedID 17714632

Stanford Medicine Resources:

Footer Links: